Live Breaking News & Updates on Destiny Crc02 Trial

Stay updated with breaking news from Destiny crc02 trial . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MOUNTAINEER and DESTINY-CRC01 Trials Expand Second-Line Options for HER2+ mCRC

Alaa Muslimani, MD, discusses the significance of the phase 2 DESTINY-CRC01 and MOUNTAINEER-03 trials on HER2-positive metastatic colorectal cancer treatment in the second line, efforts to expand the use of these agents in earlier disease settings, and the need for more robust clinical data and larger investigations for this population. ....

North Carolina , United States , Alaa Muslimani , World Congress On Gastrointestinal Cancer , Atrium Health In Charlotte , National Comprehensive Cancer Network , Levine Cancer Institute , Atrium Health , Institutional Perspectives , Mountaineer Trial , Destiny Crc01 Trial , Patients With Her2 Positive Metastatic Colorectal Cancer , Atrium Health , Mountaineer 03 Trial , Destiny Crc02 Trial , Her2 Overexpressed Advanced Or Metastatic Crc ,